Avanos Medical Statistics
Total Valuation
Avanos Medical has a market cap or net worth of $1.07 billion. The enterprise value is $1.19 billion.
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024, before market open.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Avanos Medical has 43.16 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Shares Outstanding | 43.16M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 91.89% |
| Float | 39.31M |
Valuation Ratios
The trailing PE ratio is 148.95 and the forward PE ratio is 15.37.
| PE Ratio | 148.95 |
| Forward PE | 15.37 |
| PS Ratio | 1.68 |
| Forward PS | 1.47 |
| PB Ratio | 0.93 |
| P/FCF Ratio | 25.49 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.05, with an EV/FCF ratio of 28.51.
| EV / Earnings | 154.77 |
| EV / Sales | 1.75 |
| EV / EBITDA | 10.05 |
| EV / EBIT | 16.24 |
| EV / FCF | 28.51 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.28 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 5.22 |
| Interest Coverage | 5.17 |
Financial Efficiency
Return on equity (ROE) is 0.57% and return on invested capital (ROIC) is 3.13%.
| Return on Equity (ROE) | 0.57% |
| Return on Assets (ROA) | 2.76% |
| Return on Capital (ROIC) | 3.13% |
| Revenue Per Employee | $180,960 |
| Profits Per Employee | $2,042 |
| Employee Count | 3,771 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, Avanos Medical has paid $7.00 million in taxes.
| Income Tax | 7.00M |
| Effective Tax Rate | 50.00% |
Stock Price Statistics
The stock price has increased by +20.50% in the last 52 weeks. The beta is 0.91, so Avanos Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +20.50% |
| 50-Day Moving Average | 23.20 |
| 200-Day Moving Average | 20.60 |
| Relative Strength Index (RSI) | 66.63 |
| Average Volume (20 Days) | 192,993 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Avanos Medical had revenue of $682.40 million and earned $7.70 million in profits. Earnings per share was $0.17.
| Revenue | 682.40M |
| Gross Profit | 380.90M |
| Operating Income | 73.40M |
| Pretax Income | 14.70M |
| Net Income | 7.70M |
| EBITDA | 118.60M |
| EBIT | 73.40M |
| Earnings Per Share (EPS) | $0.17 |
Full Income StatementBalance Sheet
The company has $92.20 million in cash and $218.30 million in debt, giving a net cash position of -$126.10 million or -$2.92 per share.
| Cash & Cash Equivalents | 92.20M |
| Total Debt | 218.30M |
| Net Cash | -126.10M |
| Net Cash Per Share | -$2.92 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 26.62 |
| Working Capital | 265.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $61.60 million and capital expenditures -$19.80 million, giving a free cash flow of $41.80 million.
| Operating Cash Flow | 61.60M |
| Capital Expenditures | -19.80M |
| Free Cash Flow | 41.80M |
| FCF Per Share | $0.97 |
Full Cash Flow StatementMargins
Gross margin is 55.82%, with operating and profit margins of 10.76% and 1.13%.
| Gross Margin | 55.82% |
| Operating Margin | 10.76% |
| Pretax Margin | 2.05% |
| Profit Margin | 1.13% |
| EBITDA Margin | 17.38% |
| EBIT Margin | 10.76% |
| FCF Margin | 6.13% |